AstraZeneca Pharma, a Bengaluru-based pharmaceutical company, saw a significant 48% increase in net profit to Rs 58.25 crore in the fourth quarter of fiscal year 2025. The company’s results were announced after market hours, leading to a 0.78% rise in share prices to Rs 7,980 apiece on the NSE. This positive financial performance reflects the […]